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Background. Pneumocystis without obvious accompanying pathology is occasionally reported in autopsied
infant lungs. Its prevalence and signiﬁcance are unknown. Interestingly, this mild infection induces a strong acti-
vation of mucus secretion–related genes in young immunocompetent rodents that has not been explored in
infants. Excess mucus is induced by multiple airway offenders through nonspeciﬁc pathways and would explain a
cofactor role of Pneumocystis in respiratory disease. We undertook characterization of the prevalence of Pneumo-
cystis and associated mucus in infant lungs.
Methods. Samples from 128 infants (mean age, 101 days) who died suddenly and unexpectedly in Santiago
during 1999–2004 were examined for Pneumocystis using nested polymerase chain reaction (nPCR) ampliﬁcation
of the P. jirovecii mtLSU ribosomal RNA gene and immunoﬂuorescence microscopy (IF). Pneumocystis-negative
infants 28 days and older and their age-closest positives were studied for MUC5AC expression and Pneumocystis
burden by Western blot and quantitative PCR, respectively.
Results. Pneumocystis DNA was detected by nPCR in 105 of the 128 infants (82.0%) and Pneumocystis organ-
isms were visualized by IF in 99 (94.3%) of the DNA-positive infants. The infection was commonest at 3–4
months with 40 of 41 (97.6%) infants of that age testing positive. MUC5AC was signiﬁcantly increased in
Pneumocystis-positive tissue specimens (P = .013). Death was unexplained in 113 (88.3%) infants; Pneumocystis
was detected in 95 (84.0%) of them vs 10 of 15 (66.7%) with explained death (P = .28).
Conclusions. A highly focal Pneumocystis infection associated to increased mucus expression is almost univer-
sally present in the lungs of infants dying unexpectedly in the community regardless of autopsy diagnosis.
Keywords. immunocompetent; non-speciﬁc immune response; autopsy; MUC5AC; Sudden Infant Death
Syndrome (SIDS).
Most humans experience their ﬁrst contact with
Pneumocystis (ie, primary infection) shortly after birth
[1–4]. This infection is rarely diagnosed because it is
asymptomatic or may present as a mild upper respira-
tory infection [4–6]. Autopsy reports of Pneumocystis
in infants have been available for many years [7].
However, characterization of this infection has been
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hampered by the lack of a microbiological culture method for
Pneumocystis, by the low sensitivity of any method used to
diagnose Pneumocystis pneumonia in the immunocompro-
mised to detect the smaller quantities of this fungus in immu-
nocompetent individuals, and because Pneumocystis cysts do
not stain with the standard hematoxylin-and-eosin stain rou-
tinely used in most autopsies. Recent autopsy studies describe
the focal (patchy) histological distribution [8–10] and that this
infection is more frequent between the ages of 2 and 5
months [4, 5, 9–11]. This age range coincides with the most
frequent age for sudden unexpected infant death (SUID) and
bronchiolitis [12, 13]. However, the coverage extent of this age
overlap and whether it carries any pathogenic signiﬁcance for
Pneumocystis are unknown. Increasing evidence shows that
Pneumocystis induces a potent immune response in young im-
munocompetent rodents [3, 14–17], including a strong gene
activation of ClCa3, a member of the calcium-activated chlo-
ride channel family of genes expressed in the goblet airway
epithelial cell that relates to mucus secretion [14]. Mucus is
produced constitutively by goblet cells and binds virtually all
particles that land in the airway epithelium as an essential
component of the mucociliary clearance system aimed to
clean the airways from inhaled particles. This system compris-
es secretory and ciliated cells, a periciliary liquid (PCL) layer
where the cilia move to impulse the mucus, and the propelled
overlaying mucus [18]. The heights of the PCL and of the
mucus layers need ﬁne tuning to secure airway patency while
maintaining clearance efﬁciency [18–20]. Excess PCL will raise
the ﬂoating mucus layer, making it unreachable to cilia for
propulsion, and accumulating mucus could occlude narrow,
developing, and distal airways [18–21]. Mucus release is an
airway defense reaction stimulated through nonspeciﬁc path-
ways by multiple airway offenders [19–21]. A Pneumocystis-
related increase in mucus would then suggest a cofactor role
for Pneumocystis in lung disease of the immunocompetent
host that is nearly undetectable with current autopsy proce-
dures. Therefore, we undertook this cross-sectional study to
describe the prevalence, age distribution, and mucus-associated
response to the primary infection by Pneumocystis in autop-
sied infant lungs.
MATERIALS AND METHODS
Ethics Review
This study was approved by the Ethics Commissions of the
North Metropolitan Area of Health, and of the University of
Chile School of Medicine in Santiago.
Study Population and Data Collection
The Servicio Médico Legal in Santiago is the coroners’ ofﬁce in-
stitution for the Metropolitan Area of Chile. A medico-legal
autopsy is required for infants who have died in the community
in Chile. Infant autopsies performed during calls of a thanatolo-
gy specialist physician (M.G.) between 1 May 1999 and 6 July
2004 were selected for the study. Inclusion criteria were unex-
pected death at home, no hospital admission, no immunocom-
promising conditions, and normal macroscopic examination.
The forensic protocol considered clinical history, macroscopic
examination and dissection with histological sampling of major
organs, plus laboratory tests including toxicology determina-
tions. No bacterial or viral cultures were considered. Medical in-
formation including age, date of death, ﬁndings including lung
histology report, and autopsy diagnoses were collected from the
coroner’s report prior to Pneumocystis analyses. Autopsy diag-
noses were categorized for the purpose of this study as (1) unex-
plained death (no abnormal ﬁndings at autopsy, sudden infant
death syndrome); (2) unexplained death with autopsy ﬁndings
whose contributory role to death was uncertain; and (3) ex-
plained death, when a deﬁnitive cause of death was established.
(Groups 1, 2, and 3 would correspond to SUID or sudden unex-
pected death in infancy [12, 13]).
Autopsy Samples
The complete right lung was carefully removed, placed in a
sterile plastic bag, and transported to the investigatoŕs labora-
tory in an ice-pack container after obtaining legally required
samples using sterile equipment. Each lung was processed at
arrival, one at a time; lobes were dissected inside a biosafety
cabinet using new sterile equipment as described [22]. The
pleura was carefully removed to access untouched tissue using
separate sterile equipment. Small samples were obtained from
deep lung tissue through 2-cm-deep multiple incisions in the
decorticated surface of each lobe. Specimens were cut into
small pieces and distributed for nested polymerase chain reac-
tion (nPCR) and microscopy. Lobes were processed and ana-
lyzed separately.
Samples for Pneumocystis Categorization
DNA was extracted and puriﬁed from a median of 0.172 g
(mean, 0.168 g [range, 0.099–0.226 g]) of pulmonary tissue using
the QIAamp DNAMini Kit (Qiagen, Valencia, California) moni-
toring for cross-contamination [22]. Pneumocystis jirovecii DNA
was identiﬁed by nPCR using human β-globin internal controls
[22]. Standard cleaning and sterilization procedures using DNA
breaking ﬂuids (DNA Away, VWR Scientiﬁc Products) were ap-
plied to the biosafety cabinet and hood units between each lung.
Infants were categorized as Pneumocystis positive when the
P. jirovecii DNA–speciﬁc 267 bp band was visualized in 1 or
more specimens, and as Pneumocystis negative if no P. jirovecii
DNA was documented in the 3 lobes. Pneumocystis-negative
lobes were analyzed twice, starting from tissue.
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Microscopy Analyses
A median of 0.396 g (mean, 0.399 g [range, 0.319–0.498 g]) of
lung tissue was homogenized by magnetic stirrer agitation in
sterile phosphate-buffered saline (PBS) pH 7.2 at 4°C for 30
minutes, sterile gauze ﬁltered, centrifuged at 2900g, 10
minutes at 4°C, and the pellet was reconstituted in 700 µL of
sterile PBS pH 7.2. Five-microliter drops were used for micros-
copy slides. Forms of Pneumocystis were identiﬁed using im-
munoﬂuorescence stain (MeriFluo Kit Biosciences, Cincinnati,
Ohio) in the 128 infants. Each sample was analyzed separately
and blinded to nPCR results. The 3 lobes per infant were ana-
lyzed in duplicate for each lobe.
Additional Microscopy Methods
The ﬁrst 36 of the 128 infant samples were additionally
studied using Gomori-Grocott methenamine silver and Rapid
Giemsa (Diff-Quick) staining of lung section imprints. For
either microscopy technique, infants were considered “posi-
tive” when typical Pneumocystis forms were identiﬁed and
agreed on by 2 observers (R.B. and C.P. or S.L.V.) in 1 or
more lobes and “negative” if the 3 lobes contained no Pneu-
mocystis. Interpretation was performed blinded to the results
obtained using other techniques. Microscopy reading took up
to 45 minutes per patient.
Samples for P. jirovecii and MUC5AC Quantiﬁcations
Additional lung samples (1 g) were obtained from 59 infants
comprising all 20 Pneumocystis-negative infants older than 28
days, and 39 Pneumocystis-positive infants of closest possible
age. Samples were ﬂash-frozen, pulverized in liquid nitrogen
using a mortar and pestle, homogenized, and frozen until
quantitative PCR (qPCR) and Western blot analysis.
Pneumocystis jirovecii Quantiﬁcation
DNA was extracted from a 0.4-g aliquot. The multicopy msg
gene was selected as target using primers PC MSG Forward
(5′-CAA AAA TAA CAY TSA CAT CAA CRA GG-3′) and
PC MSG Reverse (5′-AAA TCA TGA ACG AAA TAA CCA
TTG C-3′) generating a fragment of 156 bp [23] that was
cloned in pGEM-T Easy vector (Promega), and used for gen-
erating a calibration curve (range of 1 × 101 to 1 × 106 copies/μL).
Ampliﬁed product was detected using SYBR Green I (Quan-
tace, Bioscan). Quantitative PCR was done in triplicate using
the LightCycler 2.0 (Roche) with preincubation period of 10
minutes at 95°C and 46 cycles of 10 seconds at 95°C, 10
seconds at 53°C, and 20 seconds at 72°C each, ending with 7
minutes at 72°C. Each run included negative (ultrapure H2O)
and positive (DNA from a patient with Pneumocystis pneumo-
nia) controls and 3 different plasmid standards used in the
calibration curve. The speciﬁcity of ampliﬁed products was
veriﬁed by melting-curve analysis. Human β-globin gene was
used as internal control and for normalization of results as
described [5, 24].
Mucin Determinations
Each aliquot (0.6 g) and a gastric tissue sample (control) were
disrupted using a Tissue Tearor (Biospec) in chilled RIPA-
modiﬁed lysis buffer. Total protein was quantiﬁed in super-
natant by Bradford (Bio-Rad). Thirty-microgram aliquots
were subject to sodium dodecyl sulfate polyacrylamide gel
electrophoresis (4% stacking and 8% resolving Tris-Glycine
gels). Proteins were transferred to polyvinylidene diﬂuoride
membranes and blocked. Mouse anti-MUC5AC
immunoglobulin G (IgG) antibody (1:500, 45M1, SCBT) and
goat antimouse IgG horseradish peroxidase (HRP)–conjugated
antibody (1:2000, SCBT) were used for MUC5AC detection.
Membranes were stripped, blocked, and reprobed using stan-
dard antiactin antibodies (goat antiactin IgG, 1:2000, SCBT
and donkey antigoat IgG HRP, 1:3000, SCBT). Enhanced
chemiluminescence reagent was used for membrane develop-
ment (Pierce ECL WB Substrate, Thermo Scientiﬁc). Films
were analyzed with Image J software (National Institutes of
Health).
Statistical Analysis
GraphPad Prism 5 software (San Diego, California) was used
to compare prevalence of Pneumocystis in explained vs unex-
plained deaths using χ2 with Yates’ correction, Pneumocystis
(MSG copies) at sequential age intervals using analysis of vari-
ance, MUC5AC expression according to Pneumocystis pres-
ence using unpaired t test with Welch’s correction, and to
analyze the correlation between expression of MUC5AC and
Pneumocystis MSG copies using Pearson test. A P value of
<.05 was considered signiﬁcant.
RESULTS
Infants and Lung Sample Characteristics
A total of 669 infants (aged 3 days to 12 months) underwent a
legally required autopsy at Servicio Médico Legal during the
enrollment period. M.G. conducted 134 infant autopsies that
fulﬁlled entry criteria and in which the right lung was submit-
ted for analysis. Six newborn infants (mean age, 14.8 days;
median, 17 days; range, 2–22 days) were excluded because of
recent hospitalization, and 128 infants with a median age of 2
months 29 days (mean, 3 months 11 days [range, 7 days to 11
months 27 days]), 70 (54.7%) male, were considered for this
study. Infants were assigned to speciﬁc diagnostic categories
after autopsy completion (Table 1). Complete right lungs were
obtained in 111 infants, 2 lobes in 3 and, 1 lobe in 14,
respectively.
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Sensitivity of Diagnostic Techniques
Pneumocystis jirovecii DNA was detected by nPCR in the ﬁrst
36 infants studied; 34 (94.4%) of them tested positive by immu-
noﬂuorescence microscopy, and 2 (5.6%) by single PCR in the
same homogenized tissue aliquot. Diff-Quick and Gomori-
Grocott methenamine silver stains detected Pneumocystis
trophic forms in 18 (50.0%) and cyst forms in 11 (30.6%), of
lung tissue imprints (Figures 1 and 2).
DNA Ampliﬁcation
Nested PCR detected P. jirovecii DNA in 105 (82.0%) of the
128 infants: 60 (85.7%) of 70 male and 45 (77.6%) of 58
female infants. Pneumocystic jirovecii DNA was detected in 88
(79.3%) of 111 infants having their 3 lobes analyzed; of them,
35 (39.8%), 21 (23.9%), and 32 (36.3%) had detectable P. jiro-
vecii DNA in 3, 2, or 1 lobes, respectively. The ﬁrst analysis
detected 80 (94%) of the 85 infants whose right upper lobe
(RUL) was P. jirovecii DNA positive (Table 1). Pneumocystis
jirovecii DNA was detected in 4 of 7 infants < 1 month of age
(Figure 3). All ampliﬁcation reactions of controls for contami-
nation of DNA extraction and puriﬁcation were negative.
Microscopy Analyses
Lung homogenate specimens from the 128 infants were ana-
lyzed by immunoﬂuorescence microscopy in addition to
nPCR, and cystic plus smaller trophic Pneumocystis forms
were detected in 99 (94.3%) of 105 infants testing positive by
nPCR. Immunoﬂuorescence was negative in all 23 infants who
were Pneumocystis DNA negative by nPCR (Table 1;
Figure 2).
Pneumocystis Quantiﬁcation
Pneumocystis normalized counts (MSG copies per nanogram
of human DNA) were higher between 2 and 5 months and
declined thereafter (P = .7630) (Figure 4).
MUC5AC Determinations
Normalized levels of MUC5AC were signiﬁcantly increased
(P = .0134) in association with the presence of Pneumocystis
(Figure 5). This increase was consistent at all age intervals
(data not shown), and independent of Pneumocystis burden
(Pearson r = 0.0908; P = .5822). MUC5AC determination
values were normalized by human actin protein expression,
and Pneumocystis MSG determinations by human β-globin
levels (mean ± SD).
DISCUSSION
This study conﬁrms Pneumocystis as the most prevalent mi-
croorganism in autopsied infant lungs identiﬁed to date, and
Table 1. Detection of Pneumocystis by Nested Polymerase Chain Reaction in Homogenized Lung-Tissue Autopsy Specimens of
Different Pulmonary Lobes from 128 Infants Dying Suddenly and Unexpectedly in the Community
Pneumocystis DNA
Contribution to Diagnosis—Any Lobec
Autopsy Result No.a RUL RML or RLL Total
Unexplained death 85 61 10 71 (83.5%)
Unexplained death with mild autopsy findings 28 18 6 24 (85.7%)
Nonspecific lung inflammation 15
Congenital malformation (compatible with life) 4
Metabolic defect (hypoglycemia) 1
Signs of infection (mild and outside the lung) 8
Explained death 15 6 4 10 (66.7%)
Bronchopneumonia 4
Congenital malformation (cardiac or brain) 2
Traumatic death 2
Asphyxia (immersion or food) 2
Systemic signs of infection (DIVC, meningitis, other) 5
Total 128 85 (80.9%)b 20 (19.1%)b 105 (82.0%)
Abbreviations: DIVC, disseminated intravascular coagulopathy; RLL, right lower lobe; RML, right middle lobe; RUL, right upper lobe.
a Age: mean, 3 mo 11 d; median, 2 mo 29 d; range, 7 d to 11 mo 27 d.
b Percentage relative to the 105 Pneumocystis DNA–positive infants to indicate that 80.9% of positives was detected by analyzing the RUL and 19.1% additional
positives by analyzing the RML or RLL specimens. For the purpose of this study, infants were considered to be negative for Pneumocystis DNA after analysis of
2 samples in each lobe.
c Prevalence of Pneumocystis DNA among unexplained vs explained deaths, P = .28.
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that Pneumocystis presence associates to increased mucus
(MUC5AC) expression, suggesting that it increases the muco-
ciliary clearance workload and upregulates innate immune re-
sponses in the airway epithelium [19–21].
Pneumocystis cells and P. jirovecii–speciﬁc DNA were iden-
tiﬁed in the lungs of nearly all infants in this study using im-
munoﬂuorescence microscopy and nPCR, respectively. This
high prevalence is consistent with previous evidence that
Pneumocystis is common in infant lungs [9, 10] including a
study documenting Pneumocystis DNA by nPCR in all of 58
infants of undisclosed age [25]. Furthermore, the structural
forms of the fungus were all recognized using Giemsa and
GMS stains, suggesting active replication [26].
The comprehensive diagnostic approach utilized in this
study, including examination of up to 6 fresh homogenized
tissue samples per infant, increased the sensitivity of detection
and underlines the focal distribution of Pneumocystis in the
nonimmunocompromised host [8, 9]. This approach detects
smaller burdens of Pneumocystis than present in immunocom-
promised patients with Pneumocystis pneumonia, where the
fungus is readily diagnosable by microscopy or single-round
PCR. Pneumocystis burden in these infant lungs, although mild,
was greater than in immunocompetent adults where diagnosis
additionally requires of tissue-concentration techniques [22].
In addition, results show that the age peak with approxi-
mately 90% of infants having detectable Pneumocystis, and the
higher normalized burden of organisms, coincide at 2–5
months. This age predominance was suggested in previous
studies [9–11] and matches the age of onset of severe Pneumo-
cystis pneumonia in immunosuppressed or debilitated infants
prior to anti-Pneumocystis prophylaxis [27, 28]. Importantly,
young age is by itself a risk factor for Pneumocystis severity
exempliﬁed by the worse prognosis of HIV-related Pneumo-
cystis pneumonia in infants whose mortality is 60% vs 10% in
adults [27, 28].
This study also documents that Pneumocystis is associated
with increased mucus production. Mucus is a gel composed
by water (97%) and solids including mucins (3%) [19, 20].
MUC5AC, the gel-forming mucin used as a marker of mucus
in this study, is the predominant solid component of mucus
in infant airways [29]. Increased normalized levels of
MUC5AC have been similarly documented in association with
many other well-recognized, less prevalent airway offenders
like respiratory viruses, bacteria, acetyl choline, cytokines,
prostaglandins, lipopolysaccharides, nitric oxide, and other
potential activators of nonspeciﬁc airway signaling pathways
as the ErbB receptor epidermal growth factor receptor (EGFR)
[20, 21]. Additional airway offenders were not studied.
MU5AC was consistently increased in Pneumocystis-positive
infants at all age intervals, suggesting that Pneumocystis pre-
disposes the host to augmented mucus responses during this
age period [19–21], and was unaffected by Pneumocystis
burden in agreement with the concept that pathogenesis for
Pneumocystis is mostly host dependent [6, 27, 30].
Pathogenically, mucins are heavily glycosylated proteins
stored in packaging intracellular granules [31]. Their release
in response to airway insults is followed by immediate mucin
hydration leading to several hundred-fold intraluminal
volume increase in milliseconds [19–21, 31]. This mechanism
could represent a risk for narrow, developing infant airways
because minor height volume changes in the airway surface
liquid can lead to small airway closure in times as short as a
breathing cycle [32]. The clinical outcome of increased mucus
depends on several factors affecting clearance including
airway surface tension, geometry, size, and effective cough
[32, 33]. Infants have airways of small diameter, with greater
elasticity and compliance, fewer collateral airway channels,
and a reduced functional residual capacity, compared with
older children or adults [34]. In addition, mucins in infants
are more acidic that may reﬂect greater viscosity [29, 34]. The
presence of Pneumocystis could therefore favor airway col-
lapse suggested as a mechanism in current hypotheses for
SUID [35, 36]. This may occur with few clinical
Figure 1. Diagnosis of Pneumocystis in infant biopsy specimens re-
quires sensitive techniques applied to homogenized tissue: Percentage of
Pneumocystis detection as relative to nested polymerase chain reaction
(n-PCR), of immunoﬂuorescence microscopy (IF), and single-round PCR in
homogenized lung tissue specimens of 36 infants. Results of microscopy
readings using rapid Giemsa (Diff-Quick) and Gomori-Grocott methena-
mine silver (GMS) stains in imprints of cruent-cut-surface lung tissue
adjacent to the sections analyzed by n-PCR and IF are also presented.
Abbreviations: IF, immunoﬂuorescence microscopy; GMS, Gomori-Grocott
methenamine silver; n-PCR, nested polymerase chain reaction; PCR, poly-
merase chain reaction.
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Figure 2. Detection of this highly focal Pneumocystis infection by microscopy examination in homogenized preparations or imprints from lung tissue
specimens. Pneumocystis forms as visualized by microscopy using immunoﬂuorescence stain in aliquots of homogenized lung biopsy specimens
(F = ×400; C and I = ×1000), or by rapid Giemsa stain (Diff-Quick) in imprints from fresh lung infant autopsy specimen sections (A, D, and G = ×400; B, F,
and H = ×1000). Arrows on each ×400 picture point to their ×1000 magniﬁcations. Bar = 10μ.
Figure 3. Pneumocystis jirovecii infection in autopsied infant lungs peaks at 3–5 months. Lung autopsy specimens from 128 infants dying in the
community were analyzed for P. jirovecii using nested polymerase chain reaction (nPCR) and immunoﬂuorescence microscopy (IF). P. jirovecii DNA was
detected in 105 (82.0%), and Pneumocystis forms were conﬁrmed by IF in 99 (94.2%) of those found positive for P. jirovecii DNA by nPCR and in 0 of
23 infants who tested negative. Each bar represents a minimum of 5 infants. Pneumocystis was additionally detected in 4 of 4, 2 of 2, 2 of 3, 2 of 3, 1
of 1, and 0 of 2 infants dying at 6, 7, 8, 9, 10, and 11 months of age, respectively.
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manifestations until most of the peripheral airways are oc-
cluded [21]. Airway collapse would be challenging to diag-
nose at autopsy as it may immediately resolve with
postmortem airway relaxation. In addition, gravitational ori-
entation of the lungs and the release of transpulmonary pres-
sure upon opening the thorax may mobilize airway secretions
and further decrease autopsy evidence.
Pneumocystis is common in the general population at any
age. Therefore, Pneumocystis-associated mucus increase may
also be relevant for chronic respiratory diseases such as
chronic obstructive pulmonary disease and cystic ﬁbrosis in
which the coexistence of mucus excess and Pneumocystis is
described [19, 37, 38].
Other pathways increase mucin in addition to the EGFR in
the ErbB family of receptors, and include tumor necrosis
factor α, STAT6, interleukin 1β, interleukin 13, and NF-κB
and may be activated by Pneumocystis [16, 17, 30, 39]. In addi-
tion, Pneumocystis may induce collateral sensitization to a
nonspeciﬁc antigen in immunocompetent mice, increasing the
number of CD45+CD11c+ antigen-presenting cells that explain
an hyper-reactive response upon a later challenge [16]. An air-
way hyperreactive response can explain airway collapse as doc-
umented in sensitized mice [40]. This type of response may be
relevant to SUID and infant bronchiolitis whose peak inciden-
ces coincide with the age peak of Pneumocystis [12, 13, 35, 41].
This autopsy study was conducted in sudden unexpected
infant deaths. This is the most frequent form of death in
apparently healthy, nonimmunocompromised infants [12].
Pneumocystis prevalence was not different in infants with un-
explained vs explained deaths in this study, in agreement with
a previous study documenting a similar incidence of Pneumo-
cystis in infants with unexplained deaths vs in those of similar
age dying of accidental causes, conﬁrming that Pneumocystis
is not sufﬁcient to cause SUID [11]. The high prevalence of
Pneumocystis in SUID, however, raises the possibility that
Pneumocystis may be a “necessary but not sufﬁcient” cause of
SUID as coadjuvant to diverse nonspeciﬁc triggers acting on
top of Pneumocystis.
Pathology reports in this study showed that inﬂammation
was absent or too mild to explain infant deaths through in-
ﬂammatory mechanisms, as in previous autopsy series [9].
Autopsy signs of a mild respiratory infection that per se does
not explain death are present in approximately half of SUID
cases [12]. The lack of evident inﬂammation in these infants
can be explained by death occurring before inﬂammation
develops, or by other reasons including focality of the infec-
tion [14]. Animal models demonstrate that the sequence
of events leading to lymphocytic response is well demar-
cated [14, 42], and delayed during low-burden infections such
as this one, until Pneumocystis multiplies and is able to induce
Figure 4. Pneumocystis organisms burden increases up to 3–5 months
of infant age and declines thereafter. Age progression of Pneumocystis
organisms load in autopsy lung samples from 39 infants dying suddenly
in the community is shown. Pneumocystis MSG quantitative polymerase
chain reaction results were normalized to nanograms of human β-globin
DNA for comparisons and expressed as the normalized mean of Pneumo-
cystis MSG copies ± SD.
Figure 5. Mucus (MUC5AC) expression is increased by Pneumocystis
presence and not inﬂuenced by organism load. Top: MUC5AC protein
expression according to Pneumocystis status in lung tissue specimens
from 39 P. jirovecii–positive and 20 P. jirovecii–negative infants (mean ±
SD). Bottom: Correlation between normalized MUC5AC protein expres-
sion and normalized quantiﬁcation values of P. jirovecii MSG in the same
lung sample specimen for each infant (Pearson r = 0.0908, P = .5822).
MUC5AC level values were normalized by human actin protein expres-
sion, and Pneumocystis MSG determinations by human β-globin levels
(mean ± SD). Abbreviation: MUC5AC, mucus.
Pneumocystis and Mucus in Autopsied Infant Lungs • CID 2013:56 (15 January) • 177
the transient inﬂammation that eliminates the pathogen in the
immunocompetent host [30].
Airway collapse may be favored by increased mucus and
could explain death in a proportion of these infants [35, 36],
suggesting that prevention of Pneumocystis-associated mucus
increase until the airway is more developed could reduce vul-
nerability to SUID and, eventually, to bronchiolitis.
Pneumocystis is the most prevalent microorganism in the
lungs of small infants. Pneumocystis-associated mucus increase
may also be relevant to older children or adults with respiratory
conditions associated with Pneumocystis and increased mucus.
Notes
Acknowledgments. We recognize the dedicated work of Isabella Eyza-
guirre Valderas and Maria Antonieta Perez Concha as part of their DVM
graduate thesis, and thank Drs Jaime Fergie and Mauricio Henríquez for
critical review of the manuscript. We are especially grateful to Dr Walter
T. Hughes for his constant advice and for his critical review of the
manuscript.
Author contributions. S. L. V. was responsible for the hypothesis, lit-
erature search, and writing the manuscript; S. L. V., C. A. P., F. P., J.-F. A.,
R. B., M. C., I. D.-J., P. I., E.-M. A., and E. D.-C. designed the categoriza-
tion of lung specimens part of the study; S. L. V., C. A. P., F. P., J.-F. A.,
and R. B. designed the mucus part of the study; M. G. performed the au-
topsies; C. A. P., M. G., F. P., J.-F. A., R. B., and S. L. V. performed the
determinations; S. L. V., C. A. P., F. P., R. F. M., and P. I. analyzed and
interpreted the data; R. F. M., C. A. P., F. P., J.-F. A., R. B., M. C., M. G.,
I. D.-J., P. I., E.-M. A., and E. D. C. critically revised the paper. S. L. V. is
the guarantor of the study.
Financial support. This work was supported by Fondo Nacional de
Desarrollo Cientíﬁco y Tecnológico (FONDECYT-Chile) (grant numbers
1060750 and 1100225 to S. L. V.). Collaboration between French and
Chilean groups was supported by the French cooperation Ministry and by
ECOS-CONICYT (travel grant C05S02 to E. D.-C. and S. L. V.). Collabo-
ration with R. F. M. was supported by Visiting Professorship funds includ-
ed in FONDECYT-Chile (grant number 1100225 to S. L. V.) and by travel
funds from University College London (to R. F. M.).
Potential conﬂicts of interest. All authors: No reported conﬂicts.
All authors have submitted the ICMJE Form for Disclosure of Potential
Conﬂicts of Interest. Conﬂicts that the editors consider relevant to the
content of the manuscript have been disclosed.
References
1. Vestereng VH, Bishop LR, Hernandez B, Kutty G, Larsen HH, Kovacs
JA. Quantitative real-time polymerase chain-reaction assay allows
characterization of Pneumocystis infection in immunocompetent mice.
J Infect Dis 2004; 189:1540–4.
2. Icenhour CR, Rebholz SL, Collins MS, Cushion MT. Early acquisition
of Pneumocystis carinii in neonatal rats as evidenced by PCR and oral
swabs. Eukaryot Cell 2002; 1:414–9.
3. Soulez B, Dei-Cas E, Charet P, Mougeot G, Caillaux M, Camus D.
The young rabbit: a nonimmunosuppressed model for Pneumocystis
carinii pneumonia. J Infect Dis 1989; 160:355–6.
4. Vargas SL, Hughes WT, Santolaya ME, et al. Search for primary infec-
tion by Pneumocystis carinii in a cohort of normal, healthy infants.
Clin Infect Dis 2001; 32:855–61.
5. Larsen HH, von Linstow ML, Lundgren B, Hogh B, Westh H, Lundg-
ren JD. Primary Pneumocystis infection in infants hospitalized with
acute respiratory tract infection. Emerg Infect Dis 2007; 13:66–72.
6. Thomas CF Jr, Limper AH. Pneumocystis pneumonia. N Engl J Med
2004; 350:2487–98.
7. Sheldon WH. Subclinical Pneumocystis pneumonitis. AMA J Dis
Child 1959; 97:287–97.
8. Morgan DJ, Vargas SL, Reyes-Mugica M, Walterspiel JN, Carver W,
Gigliotti F. Identiﬁcation of Pneumocystis carinii in the lungs of
infants dying of sudden infant death syndrome. Pediatr Infect Dis J
2001; 20:306–9.
9. Vargas SL, Ponce CA, Hughes WT, et al. Association of primary
Pneumocystis carinii infection and sudden infant death syndrome.
Clin Infect Dis 1999; 29:1489–93.
10. Vargas SL, Ponce CA, Luchsinger V, et al. Detection of Pneumocystis
carinii f. sp. hominis and viruses in presumably immunocompetent
infants who died in the hospital or in the community. J Infect Dis
2005; 191:122–6.
11. Vargas SL, Ponce CA, Galvez P, et al. Pneumocystis is not a direct cause
of sudden infant death syndrome. Pediatr Infect Dis J 2007; 26:81–3.
12. Kinney HC, Thach BT. The sudden infant death syndrome. N Engl
J Med 2009; 361:795–805.
13. Weber MA, Klein NJ, Hartley JC, Lock PE, Malone M, Sebire NJ. In-
fection and sudden unexpected death in infancy: a systematic retro-
spective case review. Lancet 2008; 371:1848–53.
14. Hernandez-Novoa B, Bishop L, Logun C, et al. Immune responses to
Pneumocystis murina are robust in healthy mice but largely absent in
CD40 ligand-deﬁcient mice. J Leukoc Biol 2008; 84:420–30.
15. Livingston RS, Besch-Williford CL, Myles MH, Franklin CL, Crim
MJRiley LK. Pneumocystis carinii infection causes lung lesions histori-
cally attributed to rat respiratory virus. Comp Med 2011; 61:45–59.
16. Swain SD, Meissner N, Han S, Harmsen A. Pneumocystis infection in
an immunocompetent host can promote collateral sensitization to re-
spiratory antigens. Infect Immun 2011; 79:1905–14.
17. Swain SD, Meissner NN, Siemsen DW, McInnerney K, Harmsen AG.
Pneumocystis elicits a STAT6-dependent, strain-speciﬁc innate
immune response and airway hyperresponsiveness. Am J Respir Cell
Mol Biol 2012; 46:290–8.
18. Knowles MR, Boucher RC. Mucus clearance as a primary innate defense
mechanism for mammalian airways. J Clin Invest 2002; 109:571–7.
19. Fahy JV, Dickey BF. Airway mucus function and dysfunction. N Engl
J Med 2010; 363:2233–47.
20. Rogers DF. Physiology of airway mucus secretion and pathophysiology
of hypersecretion. Respir Care 2007; 52:1134–46; discussion 1146–9.
21. Burgel PR, Nadel JA. Epidermal growth factor receptor-mediated
innate immune responses and their roles in airway diseases. Eur
Respir J 2008; 32:1068–81.
22. Ponce CA, Gallo M, Bustamante R, Vargas SL. Pneumocystis coloniza-
tion is highly prevalent in the autopsied lungs of the general popula-
tion. Clin Infect Dis 2010; 50:347–53.
23. Larsen HH, Masur H, Kovacs JA, et al. Development and evaluation
of a quantitative, touch-down, real-time PCR assay for diagnosing
Pneumocystis carinii pneumonia. J Clin Microbiol 2002; 40:490–4.
24. Bandt D, Monecke S. Development and evaluation of a real-time PCR
assay for detection of Pneumocystis jiroveci. Transpl Infect Dis 2007;
9:196–202.
25. Beard CB, Fox MR, Lawrence GG, et al. Genetic differences in Pneumo-
cystis isolates recovered from immunocompetent infants and from adults
with AIDS: epidemiological Implications. J Infect Dis 2005; 192:1815–8.
26. Chabe M, Vargas SL, Eyzaguirre I, et al. Molecular typing of Pneumocys-
tis jirovecii found in formalin-ﬁxed parafﬁn-embedded lung tissue sec-
tions from sudden infant death victims. Microbiology 2004; 150:1167–72.
27. Leibovitz E, Rigaud M, Pollack H, et al. Pneumocystis carinii pneumo-
nia in infants infected with the human immunodeﬁciency virus with
more than 450 CD4 T lymphocytes per cubic millimeter. N Engl
J Med 1990; 323:531–3.
28. Simonds RJ, Oxtoby MJ, Caldwell MB, Gwinn ML, Rogers MF. Pneu-
mocystis carinii pneumonia among US children with perinatally ac-
quired HIV infection. JAMA 1993; 270:470–3.
29. Rogers DF. Pulmonary mucus: pediatric perspective. Pediatr Pulmonol
2003; 36:178–88.
178 • CID 2013:56 (15 January) • Vargas et al
30. Gigliotti F, Wright TW. Immunopathogenesis of Pneumocystis carinii
pneumonia. Expert Rev Mol Med 2005; 7:1–16.
31. Verdugo P. Mucin exocytosis. Am Rev Respir Dis 1991; 144:S33–7.
32. Heil M, Hazel AL, Smith JA. The mechanics of airway closure. Respir
Physiol Neurobiol 2008; 163:214–21.
33. Widdicombe JG. Neurophysiology of the cough reﬂex. Eur Respir J
1995; 8:1193–202.
34. Schechter MS. Airway clearance applications in infants and children.
Respir Care 2007; 52:1382–90; discussion 1390–1.
35. Martinez FD. Sudden infant death syndrome and small airway occlu-
sion: facts and a hypothesis. Pediatrics 1991; 87:190–8.
36. Poets CF, Samuels MP, Southall DP. Potential role of intrapulmonary
shunting in the genesis of hypoxemic episodes in infants and young
children. Pediatrics 1992; 90:385–91.
37. Morris A, Sciurba FC, Lebedeva IP, et al. Association of chronic ob-
structive pulmonary disease severity and Pneumocystis colonization.
Am J Respir Crit Care Med 2004; 170:408–13.
38. Morris A, Wei K, Afshar K, Huang L. Epidemiology and
clinical signiﬁcance of Pneumocystis colonization. J Infect Dis 2008;
197:10–7.
39. Lai H, Rogers DF. New pharmacotherapy for airway mucus hyperse-
cretion in asthma and COPD: targeting intracellular signaling path-
ways. J Aerosol Med Pulm Drug Deliv 2010; 23:219–31.
40. Lundblad LK, Thompson-Figueroa J, Allen GB, et al. Airway hyper-
responsiveness in allergically inﬂamed mice: the role of airway closure.
Am J Respir Crit Care Med 2007; 175:768–74.
41. Nevez G, Totet A, Pautard JC, Raccurt C. Pneumocystis carinii de-
tection using nested-PCR in nasopharyngeal aspirates of immuno-
competent infants with bronchiolitis. J Eukaryot Microbiol 2001; 48
(Suppl 1):122S–3S.
42. Chen W, Mills JW, Harmsen AG. Development and resolution of
Pneumocystis carinii pneumonia in severe combined immunodeﬁcient
mice: a morphological study of host inﬂammatory responses. Int
J Exp Pathol 1992; 73:709–20.
Pneumocystis and Mucus in Autopsied Infant Lungs • CID 2013:56 (15 January) • 179
